✦ LIBER ✦

PAR1 COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT VS INFLIXIMAB FOR TREATMENT OF SEVERE RHEUMATOID ARTHRITIS IN BRAZIL

✍ Scribed by MG Saggia; FP Pina

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PAO8: THE COST-EFFECTIVENESS OF INFLIXIM

✍ M Barbieri; JB Wong; MF Drummond 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

PMS49 Cost-Effectiveness Analysis of Eta

✍ P. Guijarro; C. Crespo; M. Brosa 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PAR14 COST MINIMIZATION ANALYSIS OF RITU

✍ MG Saggia; EA Santos; V Nasciben 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PMS15 COST-EFFECTIVENESS OF THE TREATMEN

✍ E Mucino; R Rivas; L Zapata 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PMS22 COST-EFFECTIVENESS ANALYSIS OF ETA

✍ J. Vargas-Valencia; M. Sotelo-Guzmán; J.F. Mould-Quevedo; E. Muciño-Ortega; R.M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMS14 Cost-Effectiveness Analysis of Eta

✍ Zhang, Y.; Yang, L.; Dong, P.; Xie, X.; Tang, B. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB